ATARA BIOTHERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $1.05 billion as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2022-02-28
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $1.05B.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $988.10M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $695.40M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $449.80M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2021-12-31 | $1.05B 10-K · filed 2022-02-28 |
| 2020-12-31 | $988.10M 10-K · filed 2021-03-01 |
| 2019-12-31 | $695.40M 10-K · filed 2020-02-27 |
| 2018-12-31 | $449.80M 10-K · filed 2019-02-26 |
| 2017-12-31 | $231.40M 10-K · filed 2018-02-27 |
| 2016-12-31 | $130.10M 10-K · filed 2017-03-09 |
| 2015-12-31 | $68.70M 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |